Adipose tissue dysfunction as an intermediate between obesity and resulting inflammation and insulin resistance appears to be characterized by an increase in pro-inflammatory adipokines and a decrease in anti-inflammatory adipokines such as adiponectin [33]. The gene discussed is ADIPOQ; the disease is Insulin resistance.